Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/22/2014US8703759 Fused heterocyclic compounds as ion channel modulators
04/22/2014US8703758 Bicyclic compound
04/22/2014US8703757 Seed treatment with PRF
04/22/2014US8703756 Synthetic procedure and cancer treatment with cisplatin derivatives
04/22/2014US8703754 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
04/22/2014US8703753 Use of tellurium compounds for the treatment of actinic keratosis
04/22/2014US8703752 Use of mifepristone and derivatives therefor as Hedgehog protein signaling pathway modulators and applications of same
04/22/2014US8703751 Androstenediol as an indicator for assessing estrogenicity
04/22/2014US8703750 Mixtures and methods for the induction of resistance in plants
04/22/2014US8703749 Compositions and methods for treating Friedreich's Ataxia
04/22/2014US8703748 Cleaning composition for treating tissue for transplantation derived from human/animal
04/22/2014US8703747 Aminophosphinic derivatives that can be used in the treatment of pain
04/22/2014US8703746 Compounds as receptor modulators with therapeutic utility
04/22/2014US8703745 Compounds as receptor modulators with therapeutic utility
04/22/2014US8703743 Derivatives of 1-amino-2-cyclopropylethylboronic acid
04/22/2014US8703742 Boron-containing small molecules
04/22/2014US8703741 Method of treating articular pain using a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan
04/22/2014US8703740 Composition for preventing adhesion
04/22/2014US8703739 Intravascular indwelling catheter lock solution containing weak acid and container containing the same
04/22/2014US8703738 Biotinylated hexadecasaccharides, preparation and use thereof
04/22/2014US8703737 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
04/22/2014US8703736 Therapeutic target for pancreatic cancer cells
04/22/2014US8703730 Complement antagonists and uses thereof
04/22/2014US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
04/22/2014US8703726 Methods for treating prostate conditions
04/22/2014US8703725 Nutritional compositions
04/22/2014US8703724 Low-viscous anthracycline formulation
04/22/2014US8703722 Inhibitors of F18+ E coli binding
04/22/2014US8703721 Arylalkylamine compound and process for preparing the same
04/22/2014US8703720 Galactoside inhibitors of galectins
04/22/2014US8703716 Maternal sialic acid supplementation
04/22/2014US8703696 Dipeptoid prodrugs and the use thereof
04/22/2014US8703649 Pesticidal suspo-emulsion compositions
04/22/2014US8703211 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)
04/22/2014US8703209 Composition and method for modulating hydrogen ion physiology
04/22/2014US8703202 Coated tablets
04/22/2014US8703199 Pharmaceutical compositions of adsorbates of amorphous drug
04/22/2014US8703196 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
04/22/2014US8703195 Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof
04/22/2014US8703193 Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
04/22/2014US8703192 Dosage form containing pantoprazole as active ingredient
04/22/2014US8703189 Medicinal composition
04/22/2014US8703186 Abuse-resistant oral dosage forms and method of use thereof
04/22/2014US8703185 Stable pharmaceutical composition and methods of using same
04/22/2014US8703184 Delayed-release formulation for reducing the frequency of urination and method of use thereof
04/22/2014US8703183 Metformin glycinate salt for blood glucose control
04/22/2014US8703182 Light-stabilized soft capsule formulations
04/22/2014US8703181 Liposomes useful for drug delivery
04/22/2014US8703179 Mucosal formulation
04/22/2014US8703178 Percutaneous administration device of bisoprolol
04/22/2014US8703177 Abuse-resistant mucoadhesive devices for delivery of buprenorphine
04/22/2014US8703174 Joint preserving nutritional vitamin, mineral and herbal pet supplement
04/22/2014US8703172 Sphingolipids for improvement of the composition of the intestinal flora
04/22/2014US8703171 Method for easing human childbirth using a lubricant composition
04/22/2014US8703169 Implantable device having a coating comprising carrageenan and a biostable polymer
04/22/2014US8703167 Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
04/22/2014US8703165 Spiro fused 1-amino-piperdine pyrrolidine dione derivatives with pesticidal activity
04/22/2014US8703164 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
04/22/2014US8703156 Liquid formulation for deferiprone with palatable taste
04/22/2014US8703155 Method of stabilizing reduced coenzyme q10
04/22/2014US8703148 Immunogenic composition
04/22/2014US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses
04/22/2014US8703119 Injectable biodegradable polymer compositions for soft tissue repair and augmentation
04/22/2014US8703117 Cross-linked compositions
04/22/2014US8703116 Modified macromolecule
04/22/2014US8703115 Methods for preparing conjugates
04/22/2014US8703114 Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions
04/22/2014US8703113 Side-chain crystallizable polymers for medical applications
04/22/2014US8703112 Low odor coating compositions and paints
04/22/2014US8703111 Thermoplastic paste for repairing living tissues
04/22/2014US8703110 Coating system
04/22/2014US8703104 Use of metal astringents for the treatment of hairy heel warts
04/22/2014US8703100 Modified pyrazine derivatives and uses thereof
04/22/2014US8703096 Beta-amyloid PET imaging agents
04/22/2014US8703053 Antiseptic compositions, methods and systems
04/22/2014CA2781292C Novel spiropiperidine compounds
04/22/2014CA2770404C Amide derivative
04/22/2014CA2764021C Gpr 119 modulators
04/22/2014CA2752131C Novel derivatives of dihydrobenzoxathiazepines, their preparation process and pharmaceutical compositions containing them
04/22/2014CA2751187C Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
04/22/2014CA2712170C Stable pharmaceutical composition
04/22/2014CA2710194C Inhibitors of p13 kinase
04/22/2014CA2700312C An improved method for extracting cocoa procyanidins
04/22/2014CA2682230C Nucleoside phosphoramidate prodrugs
04/22/2014CA2659696C 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
04/22/2014CA2651213C Compositions comprising low-dp polymerized surfactants and methods of use thereof
04/22/2014CA2641570C Stabilization of solid thyroid drug formulations
04/22/2014CA2640662C Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating cetp-mediated disorders
04/22/2014CA2640520C Extended cycle multiphasic oral contraceptive method
04/22/2014CA2637771C Anthranilamide/2-amino-heteroarene carboxamide derivatives
04/22/2014CA2637214C Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 receptor agonist compounds
04/22/2014CA2632618C Demethylpenclomedine analogs and their use as anticancer agents
04/22/2014CA2630595C Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer
04/22/2014CA2629512C Bicyclic cinnamide compound and prophylactic or therapeutic uses thereof
04/22/2014CA2628790C Novel quinolizidine and octahydropyridopyrazine compounds
04/22/2014CA2627623C Methods for inhibiting protein kinases
04/22/2014CA2623360C Squaric acid derivatives as inhibitors of histone deacetylase
04/22/2014CA2620418C Benztropine compounds and uses thereof
04/22/2014CA2618705C Improved delivery of tetrahydrocannabinol
04/22/2014CA2612227C Pyrimidine compounds
1 ... 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 ... 7860